Clinical Trial

Natural History Study: ENPP1 Deficiency or the Early-Onset Form of ABCC6 Deficiency

Completed
View on ClinicalTrials.gov →
Summary
The purpose of this study is to characterize the natural history of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) Deficiency and the early-onset form of adenosine triphosphate binding cassette transporter subfamily C member 6 (ABCC6) Deficiency through retrospective review of medical records and other available data sources. Information collected on medical history, clinical manifestations, radiographic imaging, and other disease-related assessments may be used to support the development of future therapies for these diseases.
Trial Details
NCT Number NCT07745179
Lead Sponsor Inozyme Pharma
Conditions Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency, ATP-Binding Cassette Subfamily C Member 6 Deficiency, Generalized Arterial Calcification of Infancy, Autosomal Recessive Hypophosphatemic Rickets, PXE (Pseudoxanthoma Elasticum)
Enrollment 23 participants
Start Date 2018-12-05
Primary Completion 2023-06-08 (estimated)
Study Completion 2025-02-14 (estimated)
Updated on ClinicalTrials.gov 2026-08-04